PRKD1 and cancer: The accumulation of ROS in cancer cells promoted the survival of cancer cells by blunting the activities of PTPs, PTEN and MAPK phosphatases, thereby augmenting MAPK-ERK, PI3K-PKB/Akt and PKD-NF-kB signaling cascades [28].